REVIEW
Accepted on 05 Nov 2025
Celecoxib in Oncology: Targeting the COX-2/PGE₂ Axis to Reprogram the Tumor Immune Microenvironment and Enhance Multimodal Therapy
- 207 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Volume II: Tumour microenvironment in cancer research and drug discovery
Volume II: Tumour microenvironment in cancer research and drug discovery
2,770
Total downloads
10k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 16 Sep 2025
IDO and TDO inhibitors in cancer immunotherapy: mechanisms, clinical development, and future directions
doi 10.3389/fphar.2025.1632446
- 2,126 views
REVIEW
Published on 11 Aug 2025
Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy
doi 10.3389/fphar.2025.1643791
- 1,820 views
REVIEW
Published on 11 Jun 2025
Tiragolumab and TIGIT: pioneering the next era of cancer immunotherapy
doi 10.3389/fphar.2025.1568664
- 3,177 views
- 3 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: